You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

Saudi Chemical Co. Holding obtained the Saudi Food and Drug Authority’s (SFDA) approval to register Ticagrelor as a fully ...

Saratoga Investment Corp. BDC outperforms with a diversified portfolio and strong dividends. Find out why SAR stock is ...